<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02865824</url>
  </required_header>
  <id_info>
    <org_study_id>CMC</org_study_id>
    <nct_id>NCT02865824</nct_id>
  </id_info>
  <brief_title>Polypectomy in Patients Taking Dual Antiplatelet Agents</brief_title>
  <official_title>Effects of Antiplatelets Discontinuation in Patients Receiving Polypectomy: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Incheon St.Mary's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Incheon St.Mary's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current guidelines recommend discontinuation of antiplatelets (i.e clopidogrel) for 7 days in
      patients taking DAT (dual antiplatelet therapy) before colonoscopy and polypectomy. The
      purpose of this study was to examine if a) discontinuation of these drugs reduces bleeding
      risks during polypectomy and if b) discontinuation of these drugs increases the occurence of
      thromboembolic events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients taking dual antiplatelets (DAT) and who visited for colonoscopy were eligible for
      enrollment in this study. On enrollment, patients were randomized to two groups. One group
      continued DAT and the other group discontinued antiplatelets (i.e. clopidogrel, ticagrelor,
      prasugrel) for 7 days before colonoscopy. If polyps (â‰¤1 cm) were observed during colonoscopy,
      they were removed by cold snare polypectomy. The primary aim was to compared the delayed
      bleeding rates of the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delayed bleeding requiring hemostasis after polypectomy</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>immediate bleeding requiring hemostasis after polypectomy</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Colonic Polyps</condition>
  <arm_group>
    <arm_group_label>Continue thienopyridine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients continue dual antiplatelet therapy (DAT) before colonoscopy and all polyps are removed by cold snare polypectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Discontinue thienopyridine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients discontinue thienopyridines for 1 week before colonoscopy and all polyps are removed by cold snare polypectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Continue thienopyridine</intervention_name>
    <description>Patients continue dual antiplatelet therapies before colonoscopy. The patients continue taking thienopyridine before colonoscopy</description>
    <arm_group_label>Continue thienopyridine</arm_group_label>
    <other_name>DAT group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Discontinue thienopyridine</intervention_name>
    <description>Patients who are taking dual antiplatelet therapies stop thienopyridine one week before they undergo colonoscopy</description>
    <arm_group_label>Discontinue thienopyridine</arm_group_label>
    <other_name>Aspirin group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients over the age of 20 years undergoing routine colonoscopy

          -  patients who are taking DAT (dual antiplatelet therapy)

        Exclusion Criteria:

          -  patients not abiding to the study protocol

          -  history of inflammatory bowel disease

          -  severe comorbidities

          -  American Society of Anesthesiology class III or more

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joon Sung Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University of Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Incheon St. Mary's Hospital</name>
      <address>
        <city>Incheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2016</study_first_submitted>
  <study_first_submitted_qc>August 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2016</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Incheon St.Mary's Hospital</investigator_affiliation>
    <investigator_full_name>Joon Sung Kim</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

